Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2011 Mar 09;3110:3650-61. doi: 10.1523/JNEUROSCI.5565-10.2011.
Show Gene links
Show Anatomy links
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
Hansen KB
,
Traynelis SF
.
???displayArticle.abstract???
NMDA receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission and have been implicated in several neurological diseases. We have evaluated the mechanism of action of a class of novel subunit-selective NMDA receptor antagonists, typified by (E)-4-(6-methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)-benzoic acid (QNZ46). We found that QNZ46 inhibits NMDA receptor function in a noncompetitive and voltage-independent manner by an unconventional mechanism that requires binding of glutamate to the GluN2 subunit, but not glycine binding to the GluN1 subunit. This dependency of antagonist association on glutamate binding to GluN2 renders these compounds nominally use-dependent, since inhibition will rely on synaptic release of glutamate. Evaluation of the structural determinants responsible for the subunit-selectivity of QNZ46 revealed that these compounds act at a new site that has not previously been described. Residues residing in the part of the agonist binding domain immediately adjacent to the transmembrane helices appear to control selectivity of QNZ46 for GluN2C- and GluN2D-containing receptors. These residues are well-positioned to sense glutamate binding to GluN2 and thus to mediate glutamate-dependent actions. This new class of noncompetitive antagonists could provide an opportunity for the development of pharmacological tools and therapeutic agents that target NMDA receptors at a new site and modulate function by a novel mechanism.
Balannik,
Molecular mechanism of AMPA receptor noncompetitive antagonism.
2005,
Pubmed
,
Xenbase
Costa,
A novel family of negative and positive allosteric modulators of NMDA receptors.
2010,
Pubmed
,
Xenbase
Eswar,
Protein structure modeling with MODELLER.
2008,
Pubmed
Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed
Horak,
Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
2006,
Pubmed
Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase
Jang,
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
2004,
Pubmed
,
Xenbase
Kalia,
NMDA receptors in clinical neurology: excitatory times ahead.
2008,
Pubmed
Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Kuntal,
EasyModeller: A graphical interface to MODELLER.
2010,
Pubmed
Kussius,
Pregnanolone sulfate promotes desensitization of activated NMDA receptors.
2009,
Pubmed
Lazzaro,
Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist.
2002,
Pubmed
Menniti,
CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
2003,
Pubmed
Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed
Monyer,
Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
1992,
Pubmed
Mosley,
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
2010,
Pubmed
,
Xenbase
Petrovic,
20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor.
2005,
Pubmed
Prieto,
Gating modes in AMPA receptors.
2010,
Pubmed
Robert,
How AMPA receptor desensitization depends on receptor occupancy.
2003,
Pubmed
Rosenmund,
The tetrameric structure of a glutamate receptor channel.
1998,
Pubmed
Sobolevsky,
Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating.
2007,
Pubmed
,
Xenbase
Sobolevsky,
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
2009,
Pubmed
Talukder,
Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating.
2010,
Pubmed
,
Xenbase
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
Ulbrich,
Subunit counting in membrane-bound proteins.
2007,
Pubmed
,
Xenbase
Vicini,
Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
1998,
Pubmed
Watanabe,
Distinct spatio-temporal distributions of the NMDA receptor channel subunit mRNAs in the brain.
1993,
Pubmed
Welch,
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
2001,
Pubmed
Wo,
Unraveling the modular design of glutamate-gated ion channels.
1995,
Pubmed
Yuan,
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
2009,
Pubmed
,
Xenbase
